The Irrigated Ablation Catheter Market To Be Swept By Inorganic Growth (M&A, Partnerships, Joint Ventures, Etc.)

05/feb/2021 11:27:00 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Catheter ablation is a procedure which is used to remove the affected heart tissues that cause a heart rhythm problem. Ablation catheters are passed through the blood vessel in the neck, arm and threaded into the heart to remove the affected heart tissues that cause abnormal heart rhythm by using radiofrequency (RF) as the source of energy.

Arrhythmias occur when electrical signals in the heart do not work properly. Medicines used in arrhythmias are to control abnormal heart rhythm, but catheter ablation devices remove the affected tissue.

In February 2016, irrigated ablation catheter manufactured by Boston Scientific Corporation, received the approval from the U.S. Food and Drug Administration. Irrigated ablation catheter is used to diagnose and treat a condition called type I atrial flutter. Atrial flutter is the condition the cause heart to beat too fast leading to heart failure or stroke.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/12178  

Some of the common symptoms include palpitations, presyncope, mild dyspnea, and fatigue. Irrigation ablation catheter uses total tip cooling technology that is used to cool the catheter tip during the ablation procedure. In open irrigation catheter, radiofrequency energy is used to destroy the place in the tissue that causes atrial flutter.

Technological advancements, advanced product pipeline and growing awareness of patient safety and monitoring are some of the key drivers that are fueling the growth of irrigated ablation catheter market.

However, high research and development expenses in product development and the low awareness about irrigated ablation catheter in the developing countries is anticipated to hamper the growth of irrigated ablation catheter market.

Get TOC of This Report @  https://www.persistencemarketresearch.com/toc/12178

According to National Center for Chronic Disease Prevention and Health Promotion, atrial fibrillation cost $ 6 billion each year in the United States. Medical expenses of people suffering from atrial fibrillation are about $ 8,705 higher per year compare to people who do not have atrial fibrillation.

On the basis of regional presence, global irrigated ablation catheter market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.

North America is expected to lead the global irrigated ablation catheter market owing to advanced healthcare infrastructure, higher adoption of technologies, and availability of reimbursement policies.

Get Full Report @  https://www.persistencemarketresearch.com/checkout/12178  

Some of the major players in global irrigated ablation catheter market are Boston Scientific Corporation, Osypka AG, Biosense Webster, Inc., and others. New technologically advanced products and systems being launched in the global market, along with expansion in the emerging markets is the primary strategy adopted by major players in the global ablation catheter system market.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl